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Abstract 
Presently, nanotechnology is a multi‑trillion dollar business sector that covers a wide range of industries, such as 
medicine, electronics and chemistry. In the current era, the commercial transition of nanotechnology from research 
level to industrial level is stimulating the world’s total economic growth. However, commercialization of nanoparti‑
cles might offer possible risks once they are liberated in the environment. In recent years, the use of zebrafish (Danio 
rerio) as an established animal model system for nanoparticle toxicity assay is growing exponentially. In the cur‑
rent in‑depth review, we discuss the recent research approaches employing adult zebrafish and their embryos for 
nanoparticle toxicity assessment. Different types of parameters are being discussed here which are used to evaluate 
nanoparticle toxicity such as hatching achievement rate, developmental malformation of organs, damage in gill and 
skin, abnormal behavior (movement impairment), immunotoxicity, genotoxicity or gene expression, neurotoxicity, 
endocrine system disruption, reproduction toxicity and finally mortality. Furthermore, we have also highlighted the 
toxic effect of different nanoparticles such as silver nanoparticle, gold nanoparticle, and metal oxide nanoparticles 
(TiO2, Al2O3, CuO, NiO and ZnO). At the end, future directions of zebrafish model and relevant assays to study nano‑
particle toxicity have also been argued.
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Background
Now-a-days, nanotechnology encompasses an increasing 
impact on the industrial revolution accounting for multi-
billion-dollar business sector. Various industrial sectors, 
including tissue engineering, drug delivery, imaging, 
diagnostics, surface texturing, and bio-interfaces are cur-
rently using nanomaterials in their products [1, 2]. Hence, 
with the growing business impact of nanotechnology, 
Business Communications Company (BCC) projected 
that the nanotechnology industry was approximately 7.6 
billion USD market in 2013 which further has a potential 
to rise up to 1 trillion USD by 2020 [3]. Nanotechnology 
is upcoming as a solution across a range of industrial 
problems and also acts as a crossroad for different ena-
bling technologies like biotechnology, computational 
science, physical science, communications technology, 
cognitive science, and others [4, 5]. Mihail Roco of the 
U.S. National Nanotechnology Institute visualized four 
generations of nanotechnology [6] and expected that the 
third generation is about to appear around 2010 with 
different types of nanosystems and thousands of their 
interacting components. In accordance, until 2013, 1814 
nanoparticles products are commercially available in the 
market [7].
Nanotechnology is known for the designing, devel-
opment, description, and applications of materials at 
nanometer scale. Furthermore, engineered nanodevices 
are finding an ever-expanding range of applications due 
to the possibility of versatile modifications in their shape, 
size, surface, and chemical properties. The surface of 
nanomaterials can be modulated according to their appli-
cation such as for drug delivery the biocompatibility of 
the nanomaterials can be modified and their cell specific 
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targeting ability can also be enhanced by attaching them 
with targeting ligand [8, 9]. Presently, people are using a 
wide variety of commercially available nanoparticles for 
their daily utilities such as—(1) silver (Ag) nanoparti-
cles are used in sheets and clothing, (2) titanium dioxide 
nanoparticles are used in different cosmetics, lotions and 
creams, (3) carbon nanoparticles are used in motorcycle 
and in bicycle, and (4) clay nanoparticles are used in beer 
bottles [10]. With the growing demand of nanoparticles 
and their commercial potential, the area of nanotoxicity 
has grown considerably during the last 10–15 years and 
we are hoping that in near future it will address our seri-
ous concern. The area of nanotoxicity also addresses the 
regulatory aspects for the growing explosion in nanopar-
ticle technology. The enhanced possibility of nanoparticle 
exposure and their toxic effects on consumers and envi-
ronment is also a thoughtful issue to be highlighted [11].
In fact, there are an increasing number of literatures 
that documents the concern over toxicity for broad 
range of engineered nanoparticles/nanomaterials such 
as CNT, fullerenes, graphene metal nanoparticles, metal 
oxides nanoparticles, crystalline materials, amorphous 
materials and nano-sized polymers [12]. Various toxic-
ity experimental assays/model organisms are used time 
to time for this purpose, such as in vitro cellular assays, 
multi-cellular model organisms (such as daphnia and sea 
urchin) [13] and higher animal models like mice [14]. 
With the use of the compound material from in vitro to 
in vivo experiments, it has been observed that the higher 
animal models are more valuable in comparison to sim-
ple experimental models. Each and every year, the num-
ber of engineered nanomaterials and their products are 
continuously increasing and there is a critical need to 
develop representative model organism, able to assess 
nanotoxicity accurately and to screen the nanoparticles 
at throughput level. In this regard, zebrafish as an in vivo 
model organism has attracted scientific interest because 
of its unique features (Fig. 1).
In this depth review, firstly we focused on the advan-
tages of zebrafish that makes it a popular experimental 
animal model for various studies. Further, we described 
the different nano-toxicological assessment methods 
in detail. Afterwards, various nanomaterial toxicologi-
cal studies conducted using zebrafish model have been 
emphasized. Finally, we also highlighted the drawbacks 
and future prospects of zebrafish model for nanotoxicity 
studies.
Zebrafish: a popular experimental animal model
The global acceptance of zebrafish as a modern experi-
mental animal model is increasing gradually. This animal 
model is becoming popular in the fields of toxicology 
and biomedical research during both adult as well as 
embryonic stages. The reason for this wide recognition 
of zebrafishes as popular animal model is due to some 
exceptional set of characteristics it possesses. Some of 
them are their small size, very high reproducibility, quick 
development, transparency of the embryo and acquies-
cent to genetic as well as chemical screens [15, 16]. Addi-
tionally, we can also find extensive literature on zebrafish 
experiments. It has been noted that zebrafish is a small 
sized animal and, therefore, it can be handled without 
any difficulty. The eggs hatch rapidly, and the larvae can 
start feeding after 120  h of fertilization indicating the 
onset of experiments on zebrafish larvae from that point 
[17]. Another advantage is that the embryos are transpar-
ent, and all cells are observable since early larval stages. 
In addition, organs and tissues may also be readily visual-
ized in vivo and can be examined instantly [18, 19]. Fur-
thermore, zebrafish is known to possess high fecundity 
rate generating large number of embryos. As an example, 
the females spawn around 300 eggs per week under ulti-
mate conditions. This may result in fecundity of >300,000 
eggs per kg of the female. Additionally, it can spawn in 
the laboratory aquarium by adding flora and gravel into 
the tank [20, 21]. It has also been observed that the eggs 
hatch rapidly and organogenesis occurs quickly. As a 
result, the major organs are developed within 5–6  days 
post-fertilization (dpf) in larvae (Fig. 2). At the average of 
350 dpf, females can attain size of 38 mm while males can 
attain a maximum mean size of 35 mm with a weight of 
0.9 and 0.6 g, respectively [22]. Another major advantage 
of zebrafish is that the cardiovascular, nervous and diges-
tive systems of this model animal are similar to mammals 
[20]. In addition, highly conserved signaling pathways are 
found both in zebrafish and humans with a high level of 
genomic homology [23]. Thus, genetic analysis assess-
ment of a particular gene function by transgenic develop-
ment and knockdown experiments can also be performed 
through zebrafish with an ease [24]. Recently, National 
Fig. 1 Increasing trend in the publications in zebrafish research 
(2007–2015). Keyword (“nano” and “zebrafish”) searched was per‑
formed from PUBMED, NCBI database. Search was conducted on 14th 
July 2016
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Institutes of Health (NIH), USA, has started to encourage 
the zebrafish model organism for the analysis of different 
diseases with a genetic program [25]. Zebrafish genetic 
map has also been developed, showing  >2000 micro-
satellite markers and 400 distinct genes. As observed, 
high level of resemblance exists among the human and 
zebrafish genomes (more or less 75 % similarity) making 
it a feasible animal model for analytical studies [26].
Different model organisms and uniqueness 
of zebrafish model to understand the toxicity
Several model organisms are been explored to under-
stand the mechanism of various human diseases along 
with their genetic disorders. Frequently used organisms 
are yeast (Saccharomyces) [27], Drosophila [28], Caeno-
rhabditis elegans (C. elegans) [29], zebrafish [30], mouse 
[31], monkey [32], and many more. Drosophila or C. 
elegans are outstanding models for studying the events 
of genetic functions related to the common molecular 
machine. These models help us to understand regulatory 
molecular machinery, such as a complex of communicat-
ing proteins or a signal-transduction pathway [33, 34]. 
On the contrary vertebrate model systems such as the 
mouse, zebrafish, and monkey are most preferred models 
for the human diseased state as compared to invertebrate 
model organisms. However, vertebrate model organ-
isms are the most complex model systems among all of 
them. Both the advantages and disadvantages of all these 
animal model organisms are already discussed in previ-
ous reports [35, 36].
Among the entire vertebrate models the most widely 
studied is mouse model system. However in mouse 
model, some disadvantages are notable such as (1) 
“forward” genetics is difficult; (2) inside the mother 
embryonic manipulations and fetal experiments are com-
plicated; (3) developmental stages, as well as life cycle, is 
moderately time-consuming; (4) high cost is involved for 
animal breeding and developing animal house facilities. 
As zebrafish offers various advantages over mouse model, 
it is emerging as an important model system which can 
connect development, disease, and toxicological studies. 
Henceforth, in the present scenario zebrafish can be rep-
resented as an interesting tool for assessing nanoparticle 
toxicity [20].
Different assessment methods to evaluate 
nanoparticle toxicity
In respect to various advantages offered by zebrafish, 
as discussed above, it is a unique model from the view 
point of the environment and human safety (EHS). The 
information produced from nano EHS studies can help 
to manage the risk of nanomaterials and nanotechnol-
ogy related products in near future. The information may 
also assist us in framing the effective guidelines on pro-
tective measures, quality controls, and design strategies 
for improving nanomaterials and minimizing toxicity 
Fig. 2 Schematic diagram describes—the different stages of zebrafish development and their relevancy for nanotoxicity study
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[37–39]. Using this model organism, several specific pro-
tocols have been used for the toxicity screening which are 
as follows:
Hatching achievement analysis
Zebrafish hatching is one of the most important events 
for the researchers to understand the chemical/nanoma-
terial toxicity. Various reports described the time span 
of zebrafish embryonic developmental stages, in detail. 
Acceding to Kimmel et  al. [40] hatching occurs within 
the first 3 days. Furthermore, Villamizar et al. [41] illus-
trated that hatching event is related to a rhythmic pattern 
corresponding to the light phase. The maximum eggs are 
hatched at approximately 2 dpf and the left over hatches 
roughly at 3 dpf. The correlation of successful hatching 
efficiency and embryo toxicity is an important parameter 
to evaluate the nanotoxicity. Recently, researchers used 
TiO2 nano-particles to understand the hatching events 
and the embryo toxicity by evaluating the relationship 
between hatching success rate and hours post exposure. 
It was observed that TiO2 nanoparticles can cause pre-
mature hatching in zebrafish embryos, dose depend-
ently [42]. Ong et al. [43] also presented a view insight of 
zebrafish hatching under the effect of nanoparticle. They 
reported complete inhibition of hatching and embryo 
death within chorion upon nanoparticle exposure. They 
also concluded that nanoparticles interact with the 
hatching enzymes and thus they are responsible for tox-
icity rather than their ionic forms. Also, Vogt et al. [44] 
analyzed the chemical toxicity using zebrafish embryos at 
24–48 h post fertilization (HPF) in 96-well plates. In this 
assay, multi-well plates are used with zebrafish embryos 
with the addition of a small molecule (BCI) to analyze 
hyper-activation of FGF signaling .
Developmental malformation analysis of embryos 
and organs
Malformation of embryos and organs is another param-
eter for toxicity screening. Developmental malformation 
includes incomplete organ development such as eye or 
incomplete body part development such as incomplete 
head formation and deformities of body parts such as 
bent notochord, fin malformation and lack of pigmen-
tation. Ali and Legler [45] showed the non-lethal devel-
opmental malformations of zebrafish embryos after the 
exposure of chemical (nonylphenol) even at low dose. 
Moreover, Usenko et al. [46] evaluated of carbon fuller-
ene [C60, C70, and C60(OH)24] toxicity using zebrafish 
embryos, in vivo. They observed caudal fin malformation 
at the concentrations of 200 ppb of C60, C70 and yolk sac 
edema, pericardial edema and pectoral fin malformations 
over the concentrations of 2500 ppb of C60(OH)24. Addi-
tionally, they also observed swelling of zebrafish embryo 
and delay in development upon exposure to 5000 ppb of 
C60(OH)24. Therefore, the use of zebrafish model can be 
proposed for screening the toxicity profile of nanomate-
rials and their rapid feedback.
In vitro/in vivo imaging
Another important use of this model is to analyze the 
toxicity through in  vitro imaging. Several specific types 
of imaging techniques can be used for toxicity study. For 
instance, dynamical cell imaging of zebrafish embryos 
is a method for safety assessment which is now used by 
several scientists [47]. Additionally, high-content imag-
ing (HCI) methods also permit us to collect automated 
visual data as well as image analysis. The HCI method is 
very rapid and can be used for the chemical screening in 
zebrafish larvae [48]. Presently, whole-body imaging is 
a challenging method to understand the pathophysiol-
ogy of 3D morphological structures. Using synchrotron 
X-ray micro-CT, whole-body imaging was performed for 
hypercholesterolemic female zebrafish to understand the 
pathophysiology of 3D morphological structures [49]. 
Furthermore, in  vivo real-time imaging is also used to 
understand the toxicity as well as size-dependent trans-
port of metal nanoparticles using zebrafish embryos. 
Although the commercialization of silver (Ag) nanopar-
ticles is expanding, its toxicity is also well known [50]. 
In view of this, recently a bio-imaging study on the toxic 
effect of sodium cholate templated Ag nanoclusters dur-
ing the developmental stages of zebrafish embryo was 
conducted [51]. Thus, due to the wide application of bio-
imaging, zebrafish can be further explored to determine 
the toxicity profile of various nanomaterials.
Transgenic zebrafish as live biosensor
Transgenic zebrafish model is a potential choice in toxi-
cological studies and currently, it is also used to evaluate 
the toxicity as live biosensor (Table 1). After exposed to 
toxic chemicals, morphological changes are well noticea-
ble in zebrafish [52]. Lee et al. [53] developed a transgenic 
line of zebrafish embryos entitled as “huORFZ embryos” 
which can accurately detect various kinds of pollutants 
compounds and can be further used as water alarm sys-
tem to monitor the disposal of hazardous pollutants in 
the water bodies. The significance of cytochrome P450 
(CYPs) as an important biomarker for detecting car-
cinogen compounds, such as polycyclic aromatic hydro-
carbons (PAHs), is well reported. Therefore, Hung et al. 
[54] generated a transgenic line of zebrafish using a CYP-
green fluorescence protein (CYP-GFP) construct for live 
imaging and to detect the water toxicity level using poly-
chlorinated biphenyls (PCBs) as pollutant. They observed 
various morphological alterations in zebrafish upon 
PCB exposure suggesting the use of CYP-GFP as a live 
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biosensor. Almeida et al. [55] also developed fluorescent 
transgenic zebrafish expressing a destabilized fluorescent 
protein (DsRED) to understand the toxicity generated by 
pesticide i.e. methyl parathione. Their observations also 
suggested the use of transgenic zebrafish as a potential 
live biomarker for toxicity analysis.
Behavioral analysis
Interestingly, zebrafish behavioral response is also a sen-
sitive indicator for abnormal change in toxicity and thus 
nowadays it has become a most important parameter 
to estimate the toxicity level [56]. Within the behavio-
ral responses, swimming kinetics is the most relevant 
and highly studied parameter. It has been prominently 
recorded that swimming speed and depth were altered 
by the chemical toxicity [57]. Kokel et al. [58] generated a 
behavioral ‘barcode’ to understand the chemical toxicity. 
Behavioral abnormalities such as abnormal startle behav-
ior following a tap stimulus after exposure to gold nano-
particles at 122 dpf was evaluated by Truong et al. [59]. 
Another experiment performed by Chen et  al. [60] has 
also shown that TiO2 nanoparticles affect larval swim-
ming parameters, including velocity and activity level.
Disruption of gill, skin and endocrine system
The disruption of gills, skin and endocrine system by 
nanoparticles is another parameter to understand nano-
particle induced toxicity. It has been reported that gills 
are most important targets of waterborne objects such as 
waterborne nanoparticle. Silver ions (Ag+) generated by 
Ag nanoparticles are well documented for their acute tox-
icity, mainly due to their interaction with the gills. In the 
gills, ionic Ag+ inhibits Na+/K+-ATPase action and the 
enzymes related to Na+ and Cl– uptake, finally affecting 
osmoregulation [61, 62]. Griffitt et  al. [63] showed that 
Cu nanoparticles (insoluble forms) are extremely toxic to 
zebrafish and their suspensions may damage gills lamel-
lae. In addition reports showed that nanoparticle are also 
toxic to zebrafish skin. Researchers have observed depo-
sition in zebrafish skin upon exposure to nanoparticle 
like Ag-BSA. In the embryo skin, the nanoparticles enter 
through diffusion or endocytosis where they accumu-
late on the epidermis layer of the larvae and causes skin 
abnormalities through apoptosis [64]. Chemical exposure 
can also cause endocrine disruption in zebrafish. Tu et al. 
[65] described the endocrine disruption in zebrafish by 
chemicals and performed endocrine gene transcription 
analysis which resulted in the increased expression of the 
estrogen-responsive gene Vtg1. The results also showed 
that there is no effect on the expression of the ERα 
gene. Another experiment by Miao et  al. [66] reported 
that the titanium dioxide nanoparticles increased the 
bioconcentration of lead, and directs the interruption of 
thyroid endocrine system in larvae of zebrafish.
Immunotoxicity
Immunotoxicity is classified as the toxic effect of xeno-
biotics on the normal functioning of immune system 
through direct or indirect methods. Direct immuno-
toxicity causes immune suppression leading to reduced 
resistance against various diseases, such as cancer [67]. 
Immunotoxicity of nanoparticles has been demon-
strated by several scientists. Various studies showed 
that nanoparticles (including metal oxide nanoparti-
cles) modulate cytokine production by generating free 
radicals. Some nanoparticles have also been linked to 
allergic sensitization and can increase the tendency of 
asthma [68]. Jin and Zheng [69] reported that a toxic 
chemical like cypermethrin induces apoptosis and 
immunotoxicity in zebrafish (Danio rerio) suggesting 
the possible use of zebrafish in immunotoxicity stud-
ies. Furthermore, Zhuang et al. [70] described the enan-
tio-selective differences in the developmental toxicity 
and immunotoxicity of pyraclofoson zebrafish model. 
Several reports also suggested the use of live zebrafish 
embryos for analyzing the immunotoxic property of 
various chemicals. In this regard, Xu et  al. [71] used 
transgenic, albino or AB line, live zebrafish embryos 
to understand the immune-toxic effects of chemicals 
such as dibutylphthalate. However, more researches are 
needed on nanoparticle-based immunotoxicity analysis 
on zebrafish.
Genotoxicity
Genotoxicity is described as the damage caused to 
genetic information inside a cell due to the occurrence 
of chemical agents which results in gene mutation, chro-
mosomal alteration and DNA damage [72]. Genotoxicity 
is a main risk factor for long-term toxic effects such as 
carcinogenesis. Zebrafish model has been proposed to 
study the different chemical-induced genotoxicity using 
various techniques. Cambier et al. [73] studied genotoxic 
effects of cadmium on zebrafish through RAPD and RT 
PCR. Furthermore, genotoxic effects of gold nanoparti-
cle were also assessed using RAPD-based methodology 
on zebrafish after exposure to gold NPs [74]. In accord-
ance to the above mentioned result, Geffroy et  al. [75] 
investigated the effects of nanoparticles on genotoxicity 
through RAPD-PCR genotoxicity test in the zebrafish at 
very low doses of gold NP (36–106 ng gold/fish/day) and 
resulted in significant alteration of genome composition. 
However, to date fewer reports are available for genotoxic 
analysis of nanoparticles on zebrafish and thus more 
extensive studies are required in this area.
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Neurotoxicity
Due to the contact with toxic substances, the nervous tis-
sue gets damaged resulting in significant irregular activ-
ity of the nervous system, which is called neurotoxicity. 
These toxic substances to nerve cell are referred as neu-
rotoxins [76]. Neurotoxicity of nanoparticles has been 
determined earlier from time to time suggesting that 
nanoparticles can reach the brain and can cause neuro-
degeneration [77, 78]. In  vivo and in  vitro experiments 
discovered that combustion-derived nanoparticles are 
neurotoxic, because of the incidence of nanoparticle 
aggregation [79]. Therefore, in view of applying zebrafish 
model to determine nanoparticle neurotoxicity the radio-
protective effect of dendrofullerene nanoparticle (DF-1), 
a C60 fullerene derivative, has been assessed in zebrafish 
embryo to understand the neurotoxicity resulting in 
dose-limiting toxicity level [80].
Sheng et  al. [81] also evaluated TiO2 nanoparticle-
induced neurotoxicity using zebrafish model. It has been 
reported that TiO2 nanoparticle significantly activated 
expressions of different genes such as BDNF C-fos and 
C-jun. Conversely, this NP suppressed the expressions of 
genes such as p38, NGF, CRE resulting in the brain dam-
age of zebrafish. Such contradictory observations provide 
a requirement for evaluating the nanoparticle caused 
neurotoxicity in future studies.
Reproductive toxicity
Reproductive toxicity is also among the important 
parameters of nanoparticle toxicity measurement [82]. 
Zebrafish model is one of the best models to assess the 
reproductive toxicity due to its high reproduction rate. As 
observed, nanoparticle affects male and female reproduc-
tivity and fetal development. Wang et al. [83] assessed the 
disturbance in zebrafish reproduction after the chronic 
exposure of TiO2 nanoparticles. Their study showed 
9.5 % decrease in the collective number of zebrafish eggs 
after 13 weeks of TiO2 nanoparticle exposure.
Mortality assessment
Acute exposure to nanoparticles enhances the chance of 
critical illness as well as increase in mortality rate. Duan 
et al. [84] treated zebrafish embryos with silica nanopar-
ticles in their experimental model system and observed 
enhanced embryonic mortality. ZnO is another toxic 
nanoparticles which caused hatching delay, skin ulcera-
tion and high mortality of zebrafish [85]. It has been 
illustrated that a relationship exists between the shape 
of the nanoparticles and the mortality incidences. There-
fore, Hua et al. [86] evaluated the toxic effects of differ-
ently shaped zinc oxide nanoparticles and observed that 
ZnO nanosticks are more toxic as compare to other NPs 
resulting in increased mortality and reduced hatching in 
zebrafish. Polyamidoamine (PAMAM) is one of the sig-
nificant dendrimers containing a diamine which is used 
as versatile precursor for dendrimer-based delivery of 
active pharmaceuticals [87]. Pryor et  al. [88] showed 
100 % mortality in zebrafish at 24 hpf by PAMAM den-
drimers illustrating its toxic effects.
Other methods
Chemical toxicity screening in zebrafish model has been 
performed using both larval stage as well as adult zebrafish 
[89]. Hermsen et al. [90] developed zebrafish embryo tox-
icity (ZET) test to analyze embryo- toxicity caused by two 
classes of chemicals in a modified zebrafish embryo. In 
their study, toxicity level of six 1,2,4-triazole antifungals 
and eight glycol ethers were evaluated. Among glycol ether 
metabolites methoxyacetic acid and ethoxyacetic acid and 
among triazoles flusilazole were most potent in retard-
ing the growth and inducing malformation in zebrafish. 
Another newly developed computational analysis has also 
been used by Toxicology Research Program of the U.S. 
EPA to understand the toxicity of the chemical library. 
Through the experiments, researchers evaluated the toxic-
ity of the 309 ToxCast™ Phase I chemicals using a zebrafish 
screen [91]. In a study, whole male adult zebrafish was 
exposed to high doses of nickel chloride, cobalt chloride 
or sodium dichromate for 24 h at various concentrations 
corresponding to their respective 96 h LC values and was 
evaluated for alterations in gene expressions. Histopatho-
logical changes were observed for each metal in their tar-
get specific organs and tissues signifying the role of adult 
zebrafish as a robust model in toxicogenomics [92].
Nanotoxicology in zebrafish
Nanotoxicology is an interdisciplinary field, cross-link-
ing various subjects such as chemistry, physics, biology, 
medicine and toxicology [93, 94]. Though, this area has 
many applicative approaches yet it is still in nascent form 
and the majority of the nanotoxicology studies are con-
fined only within in vitro models. Some research groups 
performed toxicological studies using animal models 
(in vivo) which are supposed to be significant due to the 
diversity in animal physiology and anatomy in animal 
models. Recently, for this purpose zebrafish is proposed 
as one of the most successful model and notable advance-
ment has been made in nanotoxicology studies using 
zebrafish as animal model [95]. This section categorizes 
some of the currently available toxicity data of several 
nanoparticles which has been studied using zebrafish 
model.
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Silver nanoparticle
Silver nanoparticles are the most extensively studied 
nanoparticles. They are also widely used as therapeutic 
agents [96], as antimicrobial agents [97], in drug delivery 
systems [98], as biosensors [99] and in cosmetics [100]. 
Size-dependent toxicity of AgNP was observed indicat-
ing that the size of the NP is one of the important fac-
tors for their toxicity profile. Lee et  al. [101] performed 
in  vivo quantitative study and demonstrated size-
dependent transport and toxicity of Ag-NPs in zebrafish. 
In their study, they showed that Ag nanoparticle in size 
range 30–72 nm diameters were able to diffuse into the 
zebrafish embryos through chorionic pores via random 
Brownian motion and thus they can show more potent 
toxic effect. On the contrary, Bar-Ilan et al. [102] synthe-
sized AgNP in different size range (3, 10, 50 and 200 nm) 
and treated them to zebrafish embryos rearing con-
tainer. They observed that there were size independent 
100 % mortality incidences after 120 hpf. Hence, the size 
dependent toxicity profile of AgNP is still debatable. Sur-
face defect is another parameter of nanoparticle toxicity. 
George et  al. [103] verified the toxic effect and surface 
defect caused by Ag nanoparticle in both fish cell lines 
and zebrafish embryos. Furthermore, in a recent study 
George et al. [104] also showed the effect of solar light in 
increasing the toxicity of Ag.
The charge dependent transport and toxicity of pep-
tide-functionalized Ag-NPs into early developing stage 
zebrafish embryos was also demonstrated. A recent study 
concluded that Ag-peptide NPs are much more biocom-
patible than the citrated Ag NPs [105]. Choi et  al. [106] 
evaluated oxidative stress and apoptosis in zebrafish liver 
and concluded the hepatotoxic behavior of AgNPs. They 
also observed the disruption of hepatic cell cords and 
apoptotic changes in Ag nanoparticles exposed zebrafish 
due to the upregulation of p53-related pro-apoptotic 
genes such Bax, p21 and Noxa. The influence of AgNPs 
on the neurological development of zebrafish was studied 
by Xin et  al. [107].They showed that the introduction to 
AgNPs can alter the neurological development and can 
result in small head along with the presence of hypoplastic 
hind brain, little eye, and cardiac defects [107]. In view of 
the toxicity profile of AgNP, some recent studies proposed 
that the chemical transformations of Ag nanoparticles can 
be an important way to slow down the nanoparticle toxic-
ity. For instance, Devi et al. [108] proved that sulfidation 
method can delay AgNP toxicity in zebrafish model. Fur-
thermore, biosynthesis of silver nanoparticles can also be 
a better way to reduce its toxicity level [109].
Gold nanoparticle
Nanoscale gold particles have attained massive scientific 
interest due to their chemical stability and unique optical 
properties [110]. Gold nanoparticles have shown great 
potential in medical industry such as therapeutic agents, 
as photothermal therapeutic agent, as drug carriers, etc. 
[111]. Presently, gold nanoparticles are used as promising 
agents for cancer therapy [112], as imaging particles in 
optical microscopy [113] and confocal laser microscopy 
[114]. It is also used in diagnostics such as dot immu-
noassay, immunochromatography, etc. [115]. Today, 
gold nanoparticles are among the most widely studied 
nanoparticles.
Like other metal nanoparticle, cytotoxicity of gold nan-
oparticles in humans has also been reported [116, 117]. 
Therefore, to understand the in  vivo toxicity profile of 
gold nanoparticles some studies used zebrafish as in vivo 
animal model. Kim et al. [118] analyzed the toxicity out-
comes of cationic ligand functionalized gold nanoparti-
cles in the development of zebrafish embryos including 
lethality and other morphological defects. As observed, 
the functionalized gold particles caused abnormalities 
in the eye development and affected pigmentation in 
eyes leading to behavioral and neuronal damage. Harper 
et  al. [119] assessed the toxicity mapping of AuNPs of 
different sizes and surface charges (such as neutral, posi-
tive and negative surface charges) using an embryonic 
zebrafish model. They concluded that the mortality and 
other developmental disorders are closely related to 
the morphological and chemical characteristics of gold 
nanoparticles signifying of the importance of controlled 
synthesis of nanomaterials. In another similar approach, 
toxic effect of gold nanoparticles possessing three differ-
ent functional group with different surface charges on 
zebrafish embryos was assessed exhibiting hypo-loco-
motor activity and abnormal behavioral activity [59]. 
Real time in vivo imaging was further used in a different 
study to determine the size-dependent transport and tox-
icity of AuNPs in zebrafish embryos which revealed the 
presence of AuNPs inside the embryos throughout their 
whole developmental duration [50]. In addition, Dedeh 
et  al. [74] exposed zebrafish with AuNPs for 20  days at 
two concentrations i.e. 16 and 55 µg/g dry weights and 
recorded the alterations in oxidative stress, mitochon-
drial metabolism and neurotransmission.
Carbon nanotubes (CNT)
Carbon nanotube showed numerous distinctive chemi-
cal and physical characteristics which make it equivalent 
to the biological macromolecules such as antibodies, 
enzymes, plasmid DNA, etc. CNTs have become a prom-
ising candidate for the delivery of chemotherapeutic 
agents such as paclitaxel and doxorubicin, small interfer-
ing RNA (siRNA), different biological molecules, genes, 
vaccines and antibodies. This is due to the fact that 
because of high surface area it can conjugate with a wide 
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variety of therapeutic molecules [120, 121]. However, 
the toxicity of carbon nanotube is an upcoming and sig-
nificant challenge nowadays [122]. The toxicity reports 
explaining the potential impact of CNT’s on human 
health and the environment are very inadequate and 
thus it requires more studies through improved method-
ologies. Ali-Boucetta et al. [123] discussed the pitfalls in 
traditionally used in vitro models for toxicological stud-
ies and highlighted the need for more reliable model sys-
tems. They also performed MTT and the LDH assays to 
comprehend the interaction of CNT with cell cultures 
and to understand the cytotoxicity of CNT’s. Luanpit-
pong et  al. [124] described the effects of CNT on lung 
and dermal cellular behaviors which showed the poten-
tial pulmonary and dermal risk associated with CNT 
exposure.
Recently, using zebrafish model bioaccumulation and 
distribution of multiwalled CNTs was evaluated which 
showed the bioaccumulation factor of 16 L/kg fish 
wet weight [125]. Another study performed by Li et  al. 
[126] revealed CNT-induced biochemical alterations in 
zebrafish. They further demonstrated that CNT expo-
sures can stimulate the brain and gonadal alterations. In a 
different study, the toxicity level of functionalized CNT’s 
with different lengths was evaluated in zebrafish embryo 
and was further suggested that length of CNT’s also plays 
a major role in their toxicity profile, in  vivo [127]. In a 
study by FilhoJde et al. [128] CNT network pellets hav-
ing agglomerated multi-walled CNTs (MWCNTs) with a 
standard diameter about 500  nm were not found geno-
toxic to zebrafish model. However, they observed revers-
ible inflammation in the zebrafish gills.
Besides MWCNTs, the malformations and mortal-
ity induced by C60 fullerene was also studies in zebrafish 
embryo. It was observed that C60 fullerene causes dose 
dependent necrotic and apoptotic cell death in the head 
and trunk of zebrafish embryo. Although in comparison 
to C60, C60(OH)24 was found less toxic to the head region. 
Further, it was demonstrated that C60 causes oxidative 
stress and was depicted as the main reason for malforma-
tions in zebrafish embryo [46].
Metal oxide nanoparticles
Metal oxide nanomaterials are commercially used in 
different emerging areas such as information technol-
ogy, energy storage, medicine, and catalysis [129, 130]. 
Several types of metal oxide nanoparticles are used in 
industrial production of nanoparticles such as TiO2, 
ZnO, Fe3O4, Al2O3, and CrO3. Jeng and Swanson exam-
ined the toxicity of metal oxide nanoparticles where they 
observed apoptotic behavior of ZnO nanoparticles in 
cells [131]. The toxicity of metal oxide nanoparticles was 
also assessed through zebrafish model. Zhu et  al. [132] 
evaluated the toxicity of three metal oxide nanoparticles 
(TiO2, Al2O3 and ZnO) using zebrafish embryos. They 
observed tissue ulceration in zebrafish larvae exposed to 
aqueous suspensions of nZnO and ZnO/bulk. Addition-
ally, they showed that nTiO2, nZnO and nAl2O3 exerted 
toxic effects on both zebrafish embryos and larvae. An 
attractive study was performed by Palaniappan and 
Pramod to compare the effect of bulk and nano TiO2 on 
zebrafish brain by using FT-IR technique where nTiO2 
proved to be more toxic as compared to bulk TiO2 [133]. 
Similar results were again observed by Palaniappan and 
Pramod while investigating the effect of nTiO2 and bulk 
TiO2 on zebrafish by FT-Raman Spectroscopy [134]. 
Additionally, Chen et  al. [135] also explored that nano 
TiO2 causes toxicity effects to zebrafish model, and the 
chronic toxicity of TiO2 NP is concentration as well as 
time dependent. These nanoparticles get distributed and 
accumulate in different body parts of zebrafish such as 
gill, liver, heart and brain. Compared to other nanopar-
ticle, TiO2 NPs can also cross blood–brain barrier [78]. 
Transgenic zebrafish is an important line which helps 
to detect the metal oxide toxicity. It has been observed 
that some other dissolvable metal oxide nanoparticles 
such as CuO, ZnO and NiO hinders in hatching process 
of transgenic zebrafish embryos line generated using 
hsp70 and eGFP genes [136]. Bar-Ilan et  al. [137] used 
a transgenic zebrafish line (ARE:eGFP) for detecting the 
generation of oxidative stress in the larvae upon TiO2 
nanoparticles exposure. The experiment explains that 
TiO2NPs absorbs photons and produce electron–hole 
pairs that interact with water and oxygen to form cyto-
toxic ROS. Finally, researchers concluded that the TiO2 
NPs exposure to zebrafish embryos leads to malforma-
tion and death.
Drawbacks of zebrafish model for nanotoxicity 
study
To evaluate the toxicity profile of nanomaterials, 
zebrafish model was used in various studies as an in vivo 
model system. The toxicity level of these nanoparticles 
was assessed by observing the malformations and func-
tional defects in zebrafish. However, it is very clear from 
the literature survey that nanomaterial based immuno-
toxicity assay is still lacking. Additionally, due to the rapid 
developmental stages in zebrafish it is very difficult to 
perform systematic embryo-based nano-toxicity assays. 
However, automation and advanced technologies can 
help in nano-toxicity screening with zebrafish embryos. 
Several nanomaterials are used for the therapeutic pur-
pose such as drug delivery and antimicrobial therapeu-
tics. Therefore, it is needed to understand the absorption, 
distribution, metabolism and excretion (ADME) proper-
ties of these nanomaterials. However, it is ambiguous that 
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how ADME assay will perform in zebrafish model after 
nano-drug delivery.
Future prospects
Zebrafish has shown its enormous potential as an in vivo 
model for nanomaterial toxicity study. Presently, various 
molecular biology techniques and zebrafish model trans-
genic lines have been developed for this purpose. Various 
zebrafish microarrays and huge genomic resources are 
nowadays available for nanotoxicity evaluation. All these 
advance resources makes zebrafish an extremely multi-
purpose system for toxicogenomic studies of nanomate-
rial in the very near future. Proteins and genes expression 
studies of zebrafish development have the huge possi-
bility to uncover the still debated nanomaterial toxic-
ity. Although, high throughput screening systems using 
larval stages of zebrafish is already being exploited for 
nanomaterial toxicity study, there is still an enormous 
potential for nanomaterial toxicity assays.
Conclusion
Presently, zebrafish have become a smart vertebrate 
model for toxicological testing. In Germany, the zebrafish 
embryo test was introduced as a standardized ISO pro-
gram in the evaluation of chemicals. This assay can be 
used for water testing to evaluate the level of environ-
mental contaminants [138]. Furthermore, this animal 
model is much faster, cheaper and more efficient animal 
model for more than a decade [139], and this model is 
used for toxicological testing of nanomaterial. With the 
use of modern technology, the zebrafish might be able 
to become a significant alternative of other mammalian 
models for toxicological testing of nanomaterial in forth-
coming years.
Abbreviations
hsp70: heat shock protein 70; eGFP: enhanced green fluorescence protein; 
ROS: reactive oxygen species; DsRED: zebrafish transgenic lines that express 
green or red fluorescent proteins; lysC: lysozyme C; FLI‑1 gene: friend leukemia 
integration 1gene.
Authors’ contributions
CC, ARS and GS collected the data and drafted the manuscript. ARS and SSL 
revised and edited the manuscript. All authors read and approved the final 
manuscript.
Acknowledgements
This research was supported by Hallym University Research Fund, by Basic Sci‑
ence Research Program through the National Research Foundation of Korea 
(NRF) funded by the Ministry of Education (2014R1A1A4A03009388), and by 
a grant of the Korea Health Technology R&D Project through the Korea Health 
Industry Development Institute (KHIDI), funded by the Ministry of Health & 
Welfare (HI12C1265), Republic of Korea.
Competing interests
The authors declare that they have no competing interests.
Received: 10 May 2016   Accepted: 5 August 2016
References
 1. Mangematin V, Walsh S. The future of nanotechnologies. Technovation. 
2012;32:157–60.
 2. Salamanca‑Buentello F, Persad DL, Court EB, Martin DK, Daar AS, Singer 
PA. Nanotechnology and the developing world. PLoS Med. 2005;2:e97.
 3. Sabourin V, Ayande A. Commercial opportunities and market demand 
for nanotechnologies in agribusiness sector. J Technol Manag Innov. 
2015;10:40–51.
 4. Freitas RA Jr. Welcome to the future of medicine. Stud Health Technol 
Inform. 2009;149:251–6.
 5. Hyungsub C, Mody CCM. The long history of molecular electron‑
ics: microelectronics origins of nanotechnology. Soc Stud Sci. 
2009;39:11–50.
 6. Roco MC. Environmentally responsible development of nanotechnol‑
ogy. Environ Sci Technol. 2005;39:106A–12A.
 7. Vance ME, Kuiken T, Vejerano EP, McGinnis SP, Hochella MF Jr, Rejeski 
D, Hull MS. Nanotechnology in the real world: redeveloping the 
nanomaterial consumer products inventory. Beilstein J Nanotechnol. 
2015;6:1769–80.
 8. Thanh NTK, Green LAW. Functionalization of nanoparticles for biomedi‑
cal applications. Nano Today. 2010;5:213–30.
 9. Xu L, Liu Y, Chen Z, Li W, Wang L, Wu X, Ji Y, Zhao Y, Ma L, Shao Y, Chen C. 
Surface‑engineered gold nanorods: promising DNA vaccine adjuvant 
for HIV‑1 treatment. Nano Lett. 2012;12:2003–12.
 10. Tsuzuki T. Commercial‑scale production of nanoparticles. Boca Raton: 
CRC Press Taylor & Francis Group; 2013. p. 978–81.
 11. Maynard AD, Warheit DB, Philbert MA. The new toxicology of 
sophisticated materials: nanotoxicology and beyond. Toxicol Sci. 
2011;120(Suppl 1):S109–29.
 12. Seaton A, Tran L, Aitken R, Donaldson K. Nanoparticles, human health 
hazard and regulation. J R Soc Interface. 2010;7(Suppl 1):S119–29.
 13. Gambardella C, Gallus L, Gatti AM, Faimali M, Carbone S, Antisari LV. 
Toxicity and transfer of metal oxide nanoparticles from microalgae to 
sea urchin larvae. Chem Ecol. 2014;30:308–16.
 14. Gad SC. Animal models in toxicology. London: CRC Press; 2014. p. 983.
 15. Strahle U, Scholz S, Geisler R, Greiner P, Hollert H, Rastegar S, Schu‑
macher A, Selderslaghs I, Weiss C, Witters H, Braunbeck T. Zebrafish 
embryos as an alternative to animal experiments–a commentary on 
the definition of the onset of protected life stages in animal welfare 
regulations. Reprod Toxicol. 2012;33:128–32.
 16. Chakraborty C, Agoramoorthy G. Why zebrafish? Riv Biol. 2010;103:25–7.
 17. Easter SS Jr, Nicola GN. The development of vision in the zebrafish 
(Danio rerio). Dev Biol. 1996;180:646–63.
 18. Fishman MC. Zebrafish genetics: the enigma of arrival. Proc Natl Acad 
Sci USA. 1999;96:10554–6.
 19. Parichy DM, Elizondo MR, Mills MG, Gordon TN, Engeszer RE. Normal 
table of post‑embryonic zebrafish development: staging by externally 
visible anatomy of the living fish. Dev Dyn. 2009;238:2975–3015.
 20. Hsu CH, Wen ZH, Lin CS, Chakraborty C. The zebrafish model: use in 
studying cellular mechanisms for a spectrum of clinical disease entities. 
Curr Neurovasc Res. 2007;4:111–20.
 21. Spence R, Ashton R, Smith C. Oviposition decisions are mediated by 
spawning site quality in wild and domesticated zebrafish, Danio rerio. 
Behaviour. 2007;144:953–66.
 22. Ribas L, Piferrer F. The zebrafish (Danio rerio) as a model organism, with 
emphasis on applications for finfish aquaculture research. Rev Aquacult. 
2014;6:209–40.
 23. Beliaeva NF, Kashirtseva VN, Medvedeva NV, Khudoklinova I, Ipatova 
OM, Archakov AI. Zebrafish as a model organism for biomedical studies. 
Biomed Khim. 2010;56:120–31.
 24. Varshney GK, Lu J, Gildea DE, Huang H, Pei W, Yang Z, Huang SC, Schoe‑
nfeld D, Pho NH, Casero D, et al. A large‑scale zebrafish gene knockout 
resource for the genome‑wide study of gene function. Genome Res. 
2013;23:727–35.
Page 11 of 13Chakraborty et al. J Nanobiotechnol  (2016) 14:65 
 25. Rasooly RS, Henken D, Freeman N, Tompkins L, Badman D, Briggs J, 
Hewitt AT. Genetic and genomic tools for zebrafish research: the NIH 
zebrafish initiative. Dev Dyn. 2003;228:490–6.
 26. Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G. Zebrafish: a 
complete animal model for in vivo drug discovery and development. 
Curr Drug Metab. 2009;10:116–24.
 27. Delorme‑Axford E, Guimaraes RS, Reggiori F, Klionsky DJ. The yeast 
Saccharomyces cerevisiae: an overview of methods to study autophagy 
progression. Methods. 2015;75:3–12.
 28. Foriel S, Willems P, Smeitink J, Schenck A, Beyrath J. Mitochondrial 
diseases: Drosophila melanogaster as a model to evaluate potential 
therapeutics. Int J Biochem Cell Biol. 2015;63:60–5.
 29. Gonalez‑Moragas L, Roig A, Laromaine A. C. elegans as a tool for in vivo 
nanoparticle assessment. Adv Colloid Interface Sci. 2015;219:10–26.
 30. Montazerolghaem M, Nystrom L, Engqvist H, Karlsson Ott M. Zebrafish: 
A possible tool to evaluate bioactive ions. Acta Biomater. 2015;19:10–4.
 31. Iguchi Y, Michiue H, Kitamatsu M, Hayashi Y, Takenaka F, Nishiki T, Matsui 
H. Tumor‑specific delivery of BSH‑3R for boron neutron capture therapy 
and positron emission tomography imaging in a mouse brain tumor 
model. Biomaterials. 2015;56:10–7.
 32. Riccio EK, Pratt‑Riccio LR, Bianco‑Junior C, Sanchez V, Totino PR, Car‑
valho LJ, Daniel‑Ribeiro CT. Molecular and immunological tools for the 
evaluation of the cellular immune response in the neotropical monkey 
Saimiri sciureus, a non‑human primate model for malaria research. 
Malar J. 2015;14:166.
 33. Fernandes VM, Pradhan‑Sundd T, Blaquiere JA, Verheyen EM. Ras/
MEK/MAPK‑mediated regulation of heparin sulphate proteoglycans 
promotes retinal fate in the Drosophila eye‑antennal disc. Dev Biol. 
2015;402:109–18.
 34. Pastuhov SI, Hisamoto N, Matsumoto K. MAP kinase cascades regulat‑
ing axon regeneration in C. elegans. Proc Jpn Acad Ser B Phys Biol Sci. 
2015;91:63–75.
 35. Jucker M. The benefits and limitations of animal models for translational 
research in neurodegenerative diseases. Nat Med. 2010;16:1210–4.
 36. Loisel S, Ohresser M, Pallardy M, Dayde D, Berthou C, Cartron G, Watier 
H. Relevance, advantages and limitations of animal models used in the 
development of monoclonal antibodies for cancer treatment. Crit Rev 
Oncol Hematol. 2007;62:34–42.
 37. Kahru A, Dubourguier HC. From ecotoxicology to nanoecotoxicology. 
Toxicology. 2010;269:105–19.
 38. Wang J, Asbach C, Fissan H, Hülser T, Kuhlbusch TAJ, Thompson D, Pui 
DYH. How can nanobiotechnology oversight advance science and 
industry: examples from environmental, health, and safety studies of 
nanoparticles (nano‑EHS). J Nanoparticle Res. 2011;13:1373–87.
 39. Youtie J, Porter A, Shapira P, Tang L, Benn T. The use of environmental, 
health and safety research in nanotechnology research. J Nanosci 
Nanotechnol. 2011;11:158–66.
 40. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of 
embryonic development of the zebrafish. Dev Dyn. 1995;203:253–310.
 41. Villamizar N, Ribas L, Piferrer F, Vera LM, Sanchez‑Vazquez FJ. Impact of 
daily thermocycles on hatching rhythms, larval performance and sex 
differentiation of zebrafish. PLoS ONE. 2012;7:e52153.
 42. Samaee SM, Rabbani S, Jovanovic B, Mohajeri‑Tehrani MR, Haghpanah 
V. Efficacy of the hatching event in assessing the embryo toxicity of the 
nano‑sized TiO(2) particles in zebrafish: a comparison between two 
different classes of hatching‑derived variables. Ecotoxicol Environ Saf. 
2015;116:121–8.
 43. Ong KJ, Zhao X, Thistle ME, Maccormack TJ, Clark RJ, Ma G, Martinez‑
Rubi Y, Simard B, Loo JS, Veinot JG, Goss GG. Mechanistic insights 
into the effect of nanoparticles on zebrafish hatch. Nanotoxicology. 
2014;8:295–304.
 44. Vogt A, Codore H, Day BW, Hukriede NA, Tsang M. Development of 
automated imaging and analysis for zebrafish chemical screens. J Vis 
Exp. 2010;40:e1900.
 45. Ali ES, Legler J. Developmental toxicity of nonylphenol in 
zebrafish(Danio rerio) embryos. Indian J Geomarine Sci. 
2011;40:509–15.
 46. Usenko CY, Harper SL, Tanguay RL. In vivo evaluation of carbon fuller‑
ene toxicity using embryonic zebrafish. Carbon N Y. 2007;45:1891–8.
 47. Knudsen TB, Kavlock RJ, Daston GP, Stedman D, Hixon M, Kim JH. Devel‑
opmental toxicity testing for safety assessment: new approaches and 
technologies. Birth Defects Res B Dev Reprod Toxicol. 2011;92:413–20.
 48. Peravali R, Gehrig J, Giselbrecht S, Lutjohann DS, Hadzhiev Y, Muller F, 
Liebel U. Automated feature detection and imaging for high‑resolution 
screening of zebrafish embryos. Biotechniques. 2011;50:319–24.
 49. Seo E, Lim JH, Seo SJ, Lee SJ. Whole‑body imaging of a hypercholester‑
olemic female zebrafish by using synchrotron X‑ray micro‑CT. Zebrafish. 
2015;12:11–20.
 50. Browning LM, Huang T, Xu XH. Real‑time in vivo imaging of size‑
dependent transport and toxicity of gold nanoparticles in zebrafish 
embryos using single nanoparticle plasmonic spectroscopy. Interface 
Focus. 2013;3:20120098.
 51. Chandirasekar S, Chandrasekaran C, Muthukumarasamyvel T, 
Sudhandiran G, Rajendiran N. Sodium cholate‑templated blue light‑
emitting Ag subnanoclusters: in vivo toxicity and imaging in zebrafish 
embryos. ACS Appl Mater Interfaces. 2015;7:1422–30.
 52. Lee O, Green JM, Tyler CR. Transgenic fish systems and their application 
in ecotoxicology. Critical Rev Toxicol. 2015;45:124–41.
 53. Lee HC, Lu PN, Huang HL, Chu C, Li HP, Tsai HJ. Zebrafish transgenic line 
huORFZ is an effective living bioindicator for detecting environmental 
toxicants. PLoS ONE. 2014;9:e90160.
 54. Hung KW, Suen MF, Chen YF, Cai HB, Mo ZX, Yung KK. Detection of 
water toxicity using cytochrome P450 transgenic zebrafish as live 
biosensor: for polychlorinated biphenyls toxicity. Biosens Bioelectron. 
2012;31:548–53.
 55. Almeida DV, Vaz B, Azevedo Figueiredo M, Junior AS, Marins LF. Fluores‑
cent transgenic zebrafish as a biosensor for growth‑related effects of 
methyl parathion. Aquat Toxicol. 2014;152:147–51.
 56. MacPhail RC, Hunter DL, Irons TD, Padilla S. Locomotion and behavioral 
toxicity in larval zebrafish: background, methods, and data. Zebrafish 
Methods Assess Drug Saf Tox. 2011:151–164.
 57. Huang Y, Zhang J, Han X, Huang T. The use of zebrafish (Danio rerio) 
behavioral responses in identifying sublethal exposures to deltame‑
thrin. Int J Environ Res Public Health. 2014;11:3650–60.
 58. Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, 
Kim S, Werdich AA, Haggarty SJ, et al. Rapid behavior‑based identifica‑
tion of neuroactive small molecules in the zebrafish. Nat Chem Biol. 
2010;6:231–7.
 59. Truong L, Saili KS, Miller JM, Hutchison JE, Tanguay RL. Persistent adult 
zebrafish behavioral deficits results from acute embryonic exposure 
to gold nanoparticles. Comp Biochem Physiol C Toxicol Pharmacol. 
2012;155:269–74.
 60. Chen TH, Lin CY, Tseng MC. Behavioral effects of titanium dioxide nano‑
particles on larval zebrafish (Danio rerio). Mar Pollut Bull. 2011;63:303–8.
 61. Bury NR, Grosell M, Grover AK, Wood CM. ATP‑dependent silver trans‑
port across the basolateral membrane of rainbow trout gills. Toxicol 
Appl Pharmacol. 1999;159:1–8.
 62. Wood CM, Playle RC, Hogstrand C. Physiology and modeling of mecha‑
nisms of silver uptake and toxicity in fish. Environmental Toxicol Chem. 
1999;18:71–83.
 63. Griffitt RJ, Weil R, Hyndman KA, Denslow ND, Powers K, Taylor D, Barber 
DS. Exposure to copper nanoparticles causes gill injury and acute 
lethality in zebrafish (Danio rerio). Environ Sci Technol. 2007;41:8178–86.
 64. Asharani PV, Lian Wu Y, Gong Z, Valiyaveettil S. Toxicity of silver nanopar‑
ticles in zebrafish models. Nanotechnology. 2008;19:255102.
 65. Tu W, Niu L, Liu W, Xu C. Embryonic exposure to butachlor in zebrafish 
(Danio rerio): endocrine disruption, developmental toxicity and immu‑
notoxicity. Ecotoxicol Environ Saf. 2013;89:189–95.
 66. Miao W, Zhu B, Xiao X, Li Y, Dirbaba NB, Zhou B, Wu H. Effects of 
titanium dioxide nanoparticles on lead bioconcentration and toxicity 
on thyroid endocrine system and neuronal development in zebrafish 
larvae. Aquat Toxicol. 2015;161:117–26.
 67. Lankveld DP, Van Loveren H, Baken KA, Vandebriel RJ. In vitro test‑
ing for direct immunotoxicity: state of the art. Methods Mol Biol. 
2010;598:401–23.
 68. Di Gioacchino M, Petrarca C, Lazzarin F, Di Giampaolo L, Sabbioni E, 
Boscolo P, Mariani‑Costantini R, Bernardini G. Immunotoxicity of nano‑
particles. Int J Immunopathol Pharmacol. 2011;24:65S–71S.
Page 12 of 13Chakraborty et al. J Nanobiotechnol  (2016) 14:65 
 69. Jin Y, Zheng S, Fu Z. Embryonic exposure to cypermethrin induces 
apoptosis and immunotoxicity in zebrafish (Danio rerio). Fish Shellfish 
Immunol. 2011;30:1049–54.
 70. Zhuang S, Zhang Z, Zhang W, Bao L, Xu C, Zhang H. Enantioselective 
developmental toxicity and immunotoxicity of pyraclofos toward 
zebrafish (Danio rerio). Aquat Toxicol. 2015;159:119–26.
 71. Xu H, Dong X, Zhang Z, Yang M, Wu X, Liu H, Lao Q, Li C. Assessment of 
immunotoxicity of dibutyl phthalate using live zebrafish embryos. Fish 
Shellfish Immunol. 2015;45:286–92.
 72. Bolognesi C. Genotoxicity of pesticides: a review of human biomonitor‑
ing studies. Mutat Res. 2003;543:251–72.
 73. Cambier S, Gonzalez P, Durrieu G, Bourdineaud JP. Cadmium‑induced 
genotoxicity in zebrafish at environmentally relevant doses. Ecotoxicol 
Environ Saf. 2010;73:312–9.
 74. Dedeh A, Ciutat A, Treguer‑Delapierre M, Bourdineaud JP. Impact of 
gold nanoparticles on zebrafish exposed to a spiked sediment. Nano‑
toxicology. 2015;9:71–80.
 75. Geffroy B, Ladhar C, Cambier S, Treguer‑Delapierre M, Brethes D, Bour‑
dineaud JP. Impact of dietary gold nanoparticles in zebrafish at very low 
contamination pressure: the role of size, concentration and exposure 
time. Nanotoxicology. 2012;6:144–60.
 76. Segura‑Aguilar J, Kostrzewa RM. Neurotoxins and neurotoxicity mecha‑
nisms. An overview. Neurotox Res. 2006;10:263–87.
 77. Win‑Shwe TT, Fujimaki H. Nanoparticles and neurotoxicity. Int J Mol Sci. 
2011;12:6267–80.
 78. Chakraborty C, Sarkar B, Hsu CH, Wen ZH, Lin CS, Shieh PC. Future pros‑
pects of nanoparticles on brain targeted drug delivery. J Neurooncol. 
2009;93:285–6.
 79. Morimoto Y, Kobayashi N, Shinohara N, Myojo T, Tanaka I, Nakanishi J. 
Hazard assessments of manufactured nanomaterials. J Occup Health. 
2010;52:325–34.
 80. Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. In vivo 
radioprotection by the fullerene nanoparticle DF‑1 as assessed in a 
zebrafish model. Clin Cancer Res. 2006;12:7086–91.
 81. Sheng L, Wang L, Su M, Zhao X, Hu R, Yu X, Hong J, Liu D, Xu B, Zhu 
Y, et al. Mechanism of TiO2 nanoparticle‑induced neurotoxicity in 
zebrafish (Danio rerio). Environ Toxicol. 2014;31:163–75.
 82. Braydich‑Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotox‑
icity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 
2005;88:412–9.
 83. Wang J, Zhu X, Zhang X, Zhao Z, Liu H, George R, Wilson‑Rawls J, Chang 
Y, Chen Y. Disruption of zebrafish (Danio rerio) reproduction upon 
chronic exposure to TiO(2) nanoparticles. Chemosphere. 2011;83:461–7.
 84. Duan J, Yu Y, Shi H, Tian L, Guo C, Huang P, Zhou X, Peng S, Sun Z. Toxic 
effects of silica nanoparticles on zebrafish embryos and larvae. PLoS 
ONE. 2013;8:e74606.
 85. Zhu X, Zhu L, Duan Z, Qi R, Li Y, Lang Y. Comparative toxicity of several 
metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) 
early developmental stage. J Environ Sci Health Part A. 2008;43:278–84.
 86. Hua J, Vijver MG, Richardson MK, Ahmad F, Peijnenburg WJ. Particle‑
specific toxic effects of differently shaped zinc oxide nanopar‑
ticles to zebrafish embryos (Danio rerio). Environ Toxicol Chem. 
2014;33:2859–68.
 87. Chakraborty C, Pal S, Doss G, Wen Z‑H, Lin C‑S. Nanoparticles as ‘smart’ 
pharmaceutical delivery. Front Biosci. 2012;18:1030–50.
 88. Pryor JB, Harper BJ, Harper SL. Comparative toxicological assessment of 
PAMAM and thiophosphoryl dendrimers using embryonic zebrafish. Int 
J Nanomedicine. 2014;9:1947–56.
 89. Mathias JR, Saxena MT, Mumm JS. Advances in zebrafish chemical 
screening technologies. Future Med Chem. 2012;4:1811–22.
 90. Hermsen SA, van den Brandhof EJ, van der Ven LT, Piersma AH. Relative 
embryotoxicity of two classes of chemicals in a modified zebrafish 
embryotoxicity test and comparison with their in vivo potencies. Toxi‑
col In Vitro. 2011;25:745–53.
 91. Padilla S, Corum D, Padnos B, Hunter DL, Beam A, Houck KA, Sipes N, 
Kleinstreuer N, Knudsen T, Dix DJ, Reif DM. Zebrafish developmental 
screening of the toxcast phase I chemical library. Reprod Toxicol. 
2012;33:174–87.
 92. Hussainzada N, Lewis JA, Baer CE, Ippolito DL, Jackson DA, Stallings JDI. 
Whole adult organism transcriptional profiling of acute metal expo‑
sures in male zebrafish. BMC Pharmacol Toxicol. 2014;15:15.
 93. Weiss C, Diabate S. A special issue on nanotoxicology. Arch Toxicol. 
2011;85:705–6.
 94. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. Nanotoxicology. 
Occup Environ Med. 2004;61:727–8.
 95. Jang GH, Hwang MP, Kim SY, Jang HS, Lee KH. A systematic in‑vivo 
toxicity evaluation of nanophosphor particles via zebrafish models. 
Biomaterials. 2014;35:440–9.
 96. Czupryna J, Tsourkas A. Suicide gene delivery by calcium phosphate 
nanoparticles: a novel method of targeted therapy for gastric cancer. 
Cancer Biol Ther. 2006;5:1691–2.
 97. Yoon KY, Hoon Byeon J, Park JH, Hwang J. Susceptibility constants of 
Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. 
Sci Total Environ. 2007;373:572–5.
 98. Jin S, Ye K. Nanoparticle‑mediated drug delivery and gene therapy. 
Biotechnol Prog. 2007;23:32–41.
 99. Prow T, Grebe R, Merges C, Smith J, McLeod S, Leary J, Lutty G. Nanopar‑
ticle tethered biosensors for autoregulated gene therapy in hyperoxic 
endothelium. Nanomed Nanotechnol Biol Med. 2006;2:276.
 100. Perugini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, Pavanetto 
F. Effect of nanoparticle encapsulation on the photostability of the 
sunscreen agent, 2‑ethylhexyl‑p‑methoxycinnamate. Int J Pharm. 
2002;246:37–45.
 101. Lee KJ, Browning LM, Nallathamby PD, Desai T, Cherukuri PK, Xu XH. In vivo 
quantitative study of sized‑dependent transport and toxicity of single silver 
nanoparticles using zebrafish embryos. Chem Res Toxicol. 2012;25:1029–46.
 102. Bar‑Ilan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity assessments of 
multisized gold and silver nanoparticles in zebrafish embryos. Small. 
2009;5:1897–910.
 103. George S, Lin S, Ji Z, Thomas CR, Li L, Mecklenburg M, Meng H, Wang X, 
Zhang H, Xia T, et al. Surface defects on plate‑shaped silver nanoparti‑
cles contribute to its hazard potential in a fish gill cell line and zebrafish 
embryos. ACS Nano. 2012;6:3745–59.
 104. George S, Gardner H, Seng EK, Chang H, Wang C. Yu Fang CH, Richards 
M, Valiyaveettil S, Chan WK: Differential effect of solar light in increasing 
the toxicity of silver and titanium dioxide nanoparticles to a fish cell line 
and zebrafish embryos. Environ Sci Technol. 2014;48:6374–82.
 105. Lee KJ, Browning LM, Nallathamby PD, Xu XH. Study of charge‑depend‑
ent transport and toxicity of peptide‑functionalized silver nanoparticles 
using zebrafish embryos and single nanoparticle plasmonic spectros‑
copy. Chem Res Toxicol. 2013;26:904–17.
 106. Choi JE, Kim S, Ahn JH, Youn P, Kang JS, Park K, Yi J, Ryu DY. Induction 
of oxidative stress and apoptosis by silver nanoparticles in the liver of 
adult zebrafish. Aquat Toxicol. 2010;100:151–9.
 107. Xin Q, Rotchell JM, Cheng J, Yi J, Zhang Q. Silver nanoparticles 
affect the neural development of zebrafish embryos. J Appl Toxicol. 
2015;35:1481–92.
 108. Devi GP, Ahmed KB, Varsha MK, Shrijha BS, Lal KK, Anbazhagan V, 
Thiagarajan R. Sulfidation of silver nanoparticle reduces its toxicity in 
zebrafish. Aquat Toxicol. 2015;158:149–56.
 109. Sharma G, Sharma AR, Kurian M, Bhavesh R, Nam JS, Lee SS. Green 
synthesis of silver nanoparticle using Myristica fragrans (nutmeg) 
seed extract and its biological activity. Digest J Nanomat Biostruc. 
2014;9:325–32.
 110. Singhal G, Bhavesh R, Sharma AR, Singh RP. Ecofriendly biosynthesis of 
gold nanoparticles using medicianally important Ocimum basilicum 
leaf extract. Adv Sci Eng Med. 2012;4:62–6.
 111. Huang X, El‑Sayed IH, Qian W, El‑Sayed MA. Cancer cell imaging and 
photothermal therapy in the near‑infrared region by using gold 
nanorods. J Am Chem Soc. 2006;128:2115–20.
 112. Lim ZZ, Li JE, Ng CT, Yung LY, Bay BH. Gold nanoparticles in cancer 
therapy. Acta Pharmacol Sin. 2011;32:983–90.
 113. Wang G, Stender AS, Sun W, Fang N. Optical imaging of non‑fluorescent 
nanoparticle probes in live cells. Analyst. 2010;135:215–21.
 114. Klein S, Petersen S, Taylor U, Rath D, Barcikowski S. Quantitative visu‑
alization of colloidal and intracellular gold nanoparticles by confocal 
microscopy. J Biomed Opt. 2010;15:036015.
 115. Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: 
recent advances and prospects. Acta Naturae. 2011;3:34–55.
 116. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold 
nanoparticles functionalized with cationic and anionic side chains. 
Bioconjug Chem. 2004;15:897–900.
Page 13 of 13Chakraborty et al. J Nanobiotechnol  (2016) 14:65 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 117. Gerber A, Bundschuh M, Klingelhofer D, Groneberg DA. Gold nano‑
particles: recent aspects for human toxicology. J Occup Med Toxicol. 
2013;8:32.
 118. Kim KT, Zaikova T, Hutchison JE, Tanguay RL. Gold nanoparticles 
disrupt zebrafish eye development and pigmentation. Toxicol Sci. 
2013;133:275–88.
 119. Harper SL, Carriere JL, Miller JM, Hutchison JE, Maddux BL, Tanguay RL. 
Systematic evaluation of nanomaterial toxicity: utility of standardized 
materials and rapid assays. ACS Nano. 2011;5:4688–97.
 120. He H, Pham‑Huy LA, Dramou P, Xiao D, Zuo P, Pham‑Huy C. Carbon 
nanotubes: applications in pharmacy and medicine. Biomed Res Int. 
2013;2013:578290.
 121. Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and 
medicine: in vitro and in vivo detection imaging and drug delivery. 
Nano Res. 2009;2:85–120.
 122. Madani SY, Mandel A, Seifalian AM. A concise review of carbon nano‑
tube’s toxicology. Nano Rev. 2013;4
 123. Ali‑Boucetta H, Al‑Jamal KT, Kostarelos K. Cytotoxic assessment of 
carbon nanotube interaction with cell cultures. Methods Mol Biol. 
2011;726:299–312.
 124. Luanpitpong S, Wang L, Rojanasakul Y. The effects of carbon nano‑
tubes on lung and dermal cellular behaviors. Nanomedicine (Lond). 
2014;9:895–912.
 125. Maes HM, Stibany F, Giefers S, Daniels B, Deutschmann B, Baum‑
gartner W, Schaffer A. Accumulation and distribution of multiwalled 
carbon nanotubes in zebrafish (Danio rerio). Environ Sci Technol. 
2014;48:12256–64.
 126. Li J, Ying GG, Jones KC, Martin FL. Real‑world carbon nanoparticle expo‑
sures induce brain and gonadal alterations in zebrafish (Danio rerio) as 
determined by biospectroscopy techniques. Analyst. 2015;140:2687–95.
 127. Cheng J, Cheng SH. Influence of carbon nanotube length on toxicity to 
zebrafish embryos. Int J Nanomedicine. 2012;7:3731–9.
 128. FilhoJde S, Matsubara EY, Franchi LP, Martins IP, Rivera LM, Rosolen 
JM, Grisolia CK. Evaluation of carbon nanotubes network toxicity in 
zebrafish (Danio rerio) model. Environ Res. 2014;134:9–16.
 129. Fernández‐García M, Rodriguez JA. Metal oxide nanoparticles. Encyclo‑
pedia Inorganic Bioinorganic Chem. 2007.
 130. Franke ME, Koplin TJ, Simon U. Metal and metal oxide nanoparticles in 
chemiresistors: does the nanoscale matter? Small. 2006;2:36–50.
 131. Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mam‑
malian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng. 
2006;41:2699–711.
 132. Zhu X, Zhu L, Duan Z, Qi R, Li Y, Lang Y. Comparative toxicity of several 
metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio 
rerio) early developmental stage. J Environ Sci Health A Tox Hazard 
Subst Environ Eng. 2008;43:278–84.
 133. Palaniappan PR, Pramod KS. The effect of titanium dioxide on the bio‑
chemical constituents of the brain of Zebrafish (Danio rerio): an FT‑IR 
study. Spectrochim Acta A Mol Biomol Spectrosc. 2011;79:206–12.
 134. Palaniappan PLRM, Pramod KS. Raman spectroscopic investigation on 
the microenvironment of the liver tissues of Zebrafish (Danio rerio) due 
to titanium dioxide exposure. Vib Spectrosc. 2011;56:46–153.
 135. Chen J, Dong X, Xin Y, Zhao M. Effects of titanium dioxide nano‑parti‑
cles on growth and some histological parameters of zebrafish (Danio 
rerio) after a long‑term exposure. Aquat Toxicol. 2011;101:493–9.
 136. Lin S, Zhao Y, Xia T, Meng H, Ji Z, Liu R, George S, Xiong S, Wang 
X, Zhang H, et al. High content screening in zebrafish speeds up 
hazard ranking of transition metal oxide nanoparticles. ACS Nano. 
2011;5:7284–95.
 137. Bar‑Ilan O, Louis KM, Yang SP, Pedersen JA, Hamers RJ, Peterson RE, 
Heideman W. Titanium dioxide nanoparticles produce phototoxicity in 
the developing zebrafish. Nanotoxicology. 2012;6:670–9.
 138. Kanungo J, Cuevas E, Ali SF, Paule MG. Zebrafish model in drug safety 
assessment. Curr Pharm Des. 2014;20:5416–29.
 139. Spitsbergen JM, Kent ML. The state of the art of the zebrafish model for 
toxicology and toxicologic pathology research–advantages and current 
limitations. Toxicol Pathol. 2003;31(Suppl):62–87.
 140. Chang J, Ichihara G, Shimada Y, Tada‑Oikawa S, Kuroyanagi J, Zhang B, 
Suzuki Y, Sehsah R, Kato M, Tanaka T, Ichihara S. Copper oxide nanoparti‑
cles reduce vasculogenesis in transgenic zebrafish through down‑regu‑
lation of vascular endothelial growth factor expression and induction of 
apoptosis. J Nanosci Nanotechnol. 2015;15:2140–7.
 141. Jovanovic B, Ji T, Palic D. Gene expression of zebrafish embryos exposed 
to titanium dioxide nanoparticles and hydroxylated fullerenes. Ecotoxi‑
col Environ Saf. 2011;74:1518–25.
 142. Burns CG, Milan DJ, Grande EJ, Rottbauer W, MacRae CA, Fishman MC. 
High‑throughput assay for small molecules that modulate zebrafish 
embryonic heart rate. Nat Chem Biol. 2005;1:263–4.
 143. Patra CR, Kim JH, Pramanik K, d’Uscio LV, Patra S, Pal K, Ramchandran R, 
Strano MS, Mukhopadhyay D. Reactive oxygen species driven angio‑
genesis by inorganic nanorods. Nano Lett. 2011;11:4932–8.
 144. Zhang W, Lin K, Sun X, Dong Q, Huang C, Wang H, Guo M, Cui X. Toxi‑
cological effect of MPA‑CdSe QDs exposure on zebrafish embryo and 
larvae. Chemosphere. 2012;89:52–9.
 145. Sharif F, Porta F, Meijer AH, Kros A, Richardson MK. Mesoporous silica 
nanoparticles as a compound delivery system in zebrafish embryos. Int 
J Nanomed. 2012;7:1875–90.
